FDA Approves Nexium For Use In Children Ages 1-11 Years

The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms, a delayed-release capsule and liquid form. ...

Write comment to this article:

Subject:

Name:

email or site:

Code: